Alexander Nowak
Stock Analyst at Craig-Hallum
(3.69)
# 844
Out of 4,667 analysts
47
Total ratings
46.67%
Success rate
10.43%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintains: Buy | $121 → $157 | $167.88 | -6.48% | 4 | Nov 13, 2024 | |
| CVRX CVRx, Inc. | Maintains: Buy | $15 → $20 | $13.52 | +47.93% | 4 | Nov 4, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $11.41 | +48.99% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $37.48 | +52.08% | 6 | Sep 5, 2024 | |
| CELC Celcuity | Assumes: Buy | $25 → $27 | $12.78 | +111.27% | 2 | May 16, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $22.37 | -32.95% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $4.02 | +99.00% | 4 | Apr 24, 2024 | |
| AXDX Accelerate Diagnostics | Maintains: Hold | $2 → $1 | $1.70 | -41.18% | 3 | Apr 1, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $6.20 | +190.32% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $30.15 | +65.84% | 2 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $0.78 | +925.64% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $52.70 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.73 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.03 | +441.87% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $68.72 | +60.07% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $0.32 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $2.89 | +10,280.62% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $9.02 | +210.42% | 1 | Aug 31, 2020 |
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $167.88
Upside: -6.48%
CVRx, Inc.
Nov 4, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $13.52
Upside: +47.93%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $11.41
Upside: +48.99%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $37.48
Upside: +52.08%
Celcuity
May 16, 2024
Assumes: Buy
Price Target: $25 → $27
Current: $12.78
Upside: +111.27%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $22.37
Upside: -32.95%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $4.02
Upside: +99.00%
Accelerate Diagnostics
Apr 1, 2024
Maintains: Hold
Price Target: $2 → $1
Current: $1.70
Upside: -41.18%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $6.20
Upside: +190.32%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $30.15
Upside: +65.84%
May 12, 2023
Maintains: Buy
Price Target: $14 → $8
Current: $0.78
Upside: +925.64%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $52.70
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.73
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $2.03
Upside: +441.87%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $68.72
Upside: +60.07%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $0.32
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $2.89
Upside: +10,280.62%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $9.02
Upside: +210.42%